Concepedia

Kenneth J. Wildonger

KJ

Statistics

Publications

12

Citations

518

H-Index

11

Active since

1979

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kenneth J. Wildonger is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1979–2020

12

Publications

12

N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal .beta.-lactam antibiotics

W. J. Leanza, Kenneth J. Wildonger, Thomas W. Miller et al. · Journal of Medicinal Chemistry · 1979 · 163 citations

, , +9

Studies on the structures of imipenem, dehydropeptidase I-hydrolyzed imipenem, and related analogs

Ronald W. Ratcliffe, Kenneth J. Wildonger, Lisa Di Michele et al. · The Journal of Organic Chemistry · 1989 · 51 citations

, , +6

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

James M. Apgar, Robert R. Wilkening, Dann L. Parker et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 50 citations

, , +4

An efficient synthesis of 2-substituted-thio-6-hydroxyethyl-penem-3-carboxylic acids via 2-thioxopenams

W. J. Leanza, Frank DiNinno, David A. Muthard et al. · Tetrahedron · 1983 · 49 citations

, , +6

The discovery of tetrahydrofluorenones as a new class of estrogen receptor β-subtype selective ligands

Robert R. Wilkening, Ronald W. Ratcliffe, E.C. Tynebor et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 43 citations · Full text

, , +13

1–5 of 12